TP53 and breast carcinoma: We previously reported the high prevalence of highly penetrant pathogenic variants in BRCA1, BRCA2, PALB2, and TP53 genes in consecutive women presenting with advanced breast cancer at tertiary hospitals in Nigeria, Cameroon, and Uganda [7, 8].